|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 38/16 | (2006.01) |
| A61K 38/17 | (2006.01) | ||
| A61K 38/18 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61P 33/06 | (2006.01) |
| (11) | Number of the document | 3062811 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14800207.4 |
| Date of filing the European patent application | 2014-10-31 | |
| (97) | Date of publication of the European application | 2016-09-07 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-03 |
| (46) | Date of publication of the claims translation | 2019-05-10 |
| (86) | Number | PCT/US2014/063347 |
| Date | 2014-10-31 |
| (87) | Number | WO 2015/066426 |
| Date | 2015-05-07 |
| (30) | Number | Date | Country code |
| 201361898539 P | 2013-11-01 | US | |
| 201462040514 P | 2014-08-22 | US |
| (72) |
PURCELL NGAMBO, Lisa Arleen, US
HIGGINS, Sarah, J., CA
KAIN, Kevin, C., CA
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
University Health Network (UHN), 190 Elizabeth Street R. Fraser Elliott Building Room 1S-417, Toronto, Ontario M5G 2C4, CA |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Intervencijos angiopoietino pagrindu cerebrinės maliarijos gydymui |
| ANGIOPOIETIN-BASED INTERVENTIONS FOR TREATING CEREBRAL MALARIA |
| Payment date | Validity (years) | Amount | |
| 2020-09-17 | 7 | 162.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2021-10-31 |